Navigation Links
Heart Failure Drug May Help More in Higher Doses
Date:11/18/2009

Study finds increase lowers chance of hospitalization or death

TUESDAY, Nov. 17 (HealthDay News) -- For people with heart failure, high doses of the drug losartan, an angiotensin-receptor blocker (ARB), reduce the risk for hospital admission and death, a new study shows.

Though ARBs are known to benefit people with heart failure, the study focused on whether dose level makes a difference. The findings were to be presented during the American Heart Association's annual meeting, Nov. 14 to 18, in Orlando, Fla., and were published online Nov. 17 in The Lancet.

The study included 3,846 people in 30 countries who had heart failure, a left-ventricular ejection fraction of 40 percent or less and intolerance to angiotensin-converting-enzyme (ACE) inhibitors. The participants were randomly assigned to take 50 or 150 milligrams a day of losartan (Cozaar).

After a median follow-up of 4.7 years, 43 percent of those in the high-dose group and 46 percent of those in the lower-dose group had died or were admitted to hospital for heart failure.

Overall, the higher dose of losartan reduced the risk for death or admission for heart failure by 10 percent, according to the study. When looked at separately, the risk for death was 6 percent lower for the high-dose group, and the risk for hospital admission for heart failure was 13 percent lower.

Kidney impairment, low blood pressure and hyperkalemia (high levels of blood potassium that can cause potentially fatal abnormal heart rhythm) were more common in the high-dose group, the study reported.

"These findings suggest that increased doses of an ARB are needed to achieve the maximum benefit for clinical outcomes and symptoms related to heart failure in this population," wrote Dr. Marvin A. Konstam, a cardiologist at Tufts Medical Center and Tufts University School of Medicine in Boston, and his fellow researchers.

More information

The U.S. National Heart, Lung, and Blood Institute has more about heart failure.



-- Robert Preidt



SOURCE: The Lancet, news release, Nov. 17, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Heart Attack Treatment Guidelines Stress Coordination
2. Terumo Heart, Inc. Wins Top Healthcare Category Honors at AnnArbor.com's 5th Annual ‘Deals Of The Year' Award Ceremony
3. Study Reveals Evidence of Heart Disease in Ancient Egyptian Mummies
4. American College of Cardiology/American Heart Association Comment on the FDA Public Health Advisory Regarding a Drug Interaction Between Clopidogrel and Omeprazole
5. Your own stem cells can treat heart disease
6. Obesity Rolling Back Gains in Heart Health
7. The Mummies Curse: Heart Disease
8. Heartburn Drugs Can Thwart Popular Blood Thinner
9. Highlights of NHLBI-supported research presented at American Heart Associations Scientific Sessions
10. Newer heart devices significantly improve survival, complication rate and quality of life
11. Pitt part of $100 million NHLBI Bench to Bassinet effort in congenital heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... 2017 , ... Empower Brokerage, located in Southlake, Texas, intends ... , In February, 2017, Empower Brokerage introduced their new “Performance Partners” program to ... teach how to maximize their sales efforts, as well as how to best ...
(Date:3/24/2017)... ... 24, 2017 , ... “Vintage and Harvest A Cultivation of Christian Love” is ... residing in North Carolina with his wife, Anna Marie. He and his wife are ... David is also the author of “Shadow and Substance.” , “Love, the agape kind, ...
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the ... teacher preparation programs. The NCTQ report suggests, based on a review of GPA and ... improve teacher quality in the U.S. It argues that this higher bar should be ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... Oklahoma City Convention Center at 10 North Broadway Avenue, will be an educational ... of relevant, practical instruction in the management of chronic pain. , Oklahoma is ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... the families and businesses of the Norwalk and Vermillion areas, celebrates the ... Center (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer recovery ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... YORK , March 24, 2017 FinancialBuzz.com News ... Medical cannabis products ... View Research, Inc., projects that the global medical cannabis market will reach ... is a major market for the new growing industry. By ... place to legally buy and sell medical cannabis. More conservative states like ...
(Date:3/24/2017)... Today Stock-Callers.com have issued research reports ... Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences Corp. ... ). These companies are part of the Healthcare sector, which ... 23 rd , 2017, with the NYSE Health Care Index ... companies in the S&P 500 were down about 0.4% as ...
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, ... advanced medical technology for non-invasive surgery, announced today ... System for treatment of uterine fibroids throughout the ... had received approval from the US Food and ... the Mirabilis System in the United States.  The ...
Breaking Medicine Technology: